Abstract
One of the conditions associated with adrenoleukodystrophy (ALD) / adrenomyeloneuropathy (AMN) is neurogenic lower urinary tract dysfunction (LUTD). A thorough examination of patients with ALD/AMN in most cases can reveal overactive bladder (OAB), which often remains undiagnosed because its clinical manifestations are underestimated against the background of numerous neurologic symptoms. In addition, in some cases, urologic symptomatology is the first sign of ALD/AMN that prompts the urologist to consider further evaluation of the patient. In this case, the urologist can play a significant role in the patient’s life, as timely diagnosis and treatment of ALD/AMN improve disease outcomes and reduce the likelihood of complications of ALD/AMN-associated conditions. To date, there are few studies devoted to the understanding of LUTD in ALD/AMN. In this article, we reviewed the current literature on OAB in patients with ALD/AMN.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
